BLOOMINGTON (WEEK) — A new drug to fight COVID-19 could see some of its first tests in McLean County.
Bloomington-based Heritage Operations Group is working in partnership with pharmaceutical company Eli Lilly on a new drug to possibly fight the coronavirus. Known as BLAZE 2, researchers are looking to see if antibodies injected with an IV can treat or prevent infection at assisted living facilities.
The testing process is available to residents in all 45 Heritage locations. Participation in the process, however, is entirely voluntary.
"This partnership with Eli Lilly is giving us a sense of hope for our residents and for our employees that we're finally taking the offense against COVID-19," says Ben Hart, President and CEO of Heritage.
The facilities have been in contact with Lilly, and are awaiting the first visit to begin the trial.